drugset / Trial / NCT05092750

Magnetic Particle-ICG Lymph Node Mapping in Colorectal Cancer

NCT05092750

Phase 1/2 Withdrawn M.D. Anderson Cancer Center
NaSingle-groupOpen-labelDiagnostic

Summary

Study to determine the feasibility of Sentinel Lymph Node (SLN) mapping using novel magnetic tracers (FerroTrace) and indocyanine green (ICG) for colorectal cancer; and to evaluate safety by assessing short term toxicity associated with colonoscopic peritumoral injection of novel magnetic nanoparticles (FerroTrace) and ICG for colorectal cancer.

Timeline

Start
2021-09-15
Primary completion
2023-08-29
Completion
2023-08-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Indocyanine Green Diagnostic / imaging agent Subcutaneous

Indications